About 100 reports

In addition to this, the usage of surgical lasers in cosmetic dermatology for the treatment of various cutaneous pathologies is also increasing.

  • Eye Disease
  • Medical Device
  • Boston Scientific Corporation
  • Fotona d.d.
  • Lumenis Ltd.
  • Diffuse Diabetic Macular Edema

The Pathology of Dry Eye.

  • Eye Disease
  • World
  • Adverum Biotechnologies, Inc.
  • Alcon, Inc.
  • Allergan plc

Medical lasers have essentially transformed cosmetic dermatology by providing a reliable means of treating various cutaneous pathologies.

  • Eye Disease
  • Alcon, Inc.
  • IRIDEX Corporation
  • Lumenis Ltd.
  • Syneron Medical Ltd.
  • Aqueous-Deficient Dry Eye

The Pathology of Dry Eye.

  • Eye Disease
  • World
  • Market Size
  • Allergan plc
  • Novartis AG

This category includes equipment used in the examination of the eye which allows study or treatment of different pathologies of the eye.

  • Eye Disease
  • Europe
  • United Kingdom
  • Abbott Medical Optics, Inc.
  • Alcon, Inc.

This category includes equipment used in the examination of the eye which allows study or treatment of different pathologies of the eye.

  • Eye Disease
  • Mexico
  • North America
  • Market Size
  • Abbott Medical Optics, Inc.
  • 9.2 References

Pericytes at the intersection between tissue regeneration and pathology.

  • Eye Disease
  • North America
  • United States
  • Circassia Pharmaceuticals plc
  • RXi Pharmaceuticals Corporation

An ultrasonic biomicroscope is used for glaucoma screening, determining lens and cornea pathologies, or sizing phakic intraocular lenses.

  • Eye Disease
  • World
  • Market Size
  • Alcon, Inc.
  • Bausch & Lomb Incorporated

THE PATHOLOGY OF DRY EYE: THE INTERACTION BETWEEN THE OCULAR SURFACE AND LACRIMAL GLANDS.

  • Eye Disease
  • Allergan plc
  • Herantis Pharma Plc
  • RegeneRx Biopharmaceuticals, Inc.
  • Santen Pharmaceutical Co., Ltd.
  • 9.3.6 Inotek Pharmaceuticals

PATHOLOGIES ASSOCIATED WITH RAPID LOSS OF PHOTORECEPTORS (INOTEK, 2014B).

  • Eye Disease
  • World
  • Alcon, Inc.
  • Allergan plc
  • Santen Pharmaceutical Co., Ltd.

pathology to be assessed by imaging procedures Retinal or choroidal vascular disease in study eye due to causes other than PCV, such as uveitis, trauma, or pathologic myopia Macular edema in either eye due to other causes, such as diabetic retinopathy Evidence of glaucomatous eye disease, g

  • Eye Disease
  • World
  • Bayer AG
  • Lpath, Inc.
  • OXiGENE, Inc.

The pathology of dry eye: the interaction between the ocular surface and lacrimal glands.

  • Eye Disease
  • Allergan plc
  • Mitotech S.A.
  • RegeneRx Biopharmaceuticals, Inc.
  • Santen Pharmaceutical Co., Ltd.

pathologies Integrated biopharmaceutical company that develops and commercializes ophthalmic and oncology medicines in Belgium and worldwide Biopharmaceutical company that develops and commercializes stem cell therapeutics and related tools and technologies for stem cell-based research and

  • Eye Disease
  • Actavis plc
  • F. Hoffmann-La Roche Ltd.
  • Merck & Co., Inc.
  • Novartis AG
  • Trial Results
  • Patient Details

pathology (including severe dry eye) in the opinion of the Investigator that would preclude the administration of a topical prostaglandin analog or a topical betablocker Intraocular surgery within the past ## days in the study eye prior to the Screening Visit Any abnormality preventing reli

  • Eye Disease
  • World
  • Alcon, Inc.
  • Bausch & Lomb Incorporated
  • Merck & Co., Inc.

THE PATHOLOGY OF DRY EYE: THE INTERACTION BETWEEN THE OCULAR SURFACE AND LACRIMAL GLANDS.

  • Eye Disease
  • Allergan plc
  • Mimetogen Pharmaceuticals Inc.
  • Otsuka Pharmaceutical Co., Ltd.
  • Santen Pharmaceutical Co., Ltd.

The pathology of dry eye: the interaction between the ocular surface and lacrimal glands.

  • Eye Disease
  • Allergan plc
  • Mitotech S.A.
  • RegeneRx Biopharmaceuticals, Inc.
  • Santen Pharmaceutical Co., Ltd.

The pathology of dry eye: the interaction between the ocular surface and lacrimal glands.

  • Eye Disease
  • Allergan plc
  • Mitotech S.A.
  • RegeneRx Biopharmaceuticals, Inc.
  • Santen Pharmaceutical Co., Ltd.

The pathology of dry eye: the interaction between the ocular surface and lacrimal glands.

  • Eye Disease
  • Allergan plc
  • Mitotech S.A.
  • RegeneRx Biopharmaceuticals, Inc.
  • Santen Pharmaceutical Co., Ltd.

The pathology of dry eye: the interaction between the ocular surface and lacrimal glands.

  • Eye Disease
  • Allergan plc
  • Mitotech S.A.
  • RegeneRx Biopharmaceuticals, Inc.
  • Santen Pharmaceutical Co., Ltd.
  • Disease Background
  • Clinical Trial Design in Wet AMD

Journal of Pathology, ##, ##-##.

  • Eye Disease
  • Europe
  • Novartis AG
  • Ohr Pharmaceutical Inc.
  • Ophthotech Corporation

BENEFITS PROVIDED BY MEDICARE INCLUDE: CONSULTATION FESS FOR DOCTORS AND SPECIALISTS; TESTS SUCH AS X-RAY EXAMINATION, PATHOLOGY TESTS AND EYE TESTS; MOST SURGICAL AND THERAPEUTIC PROCEDURES; SURGICAL PROCEDURES APPROVED BY DENTISTS; AS WELL AS SPECIFIC ITEMS UNDER THE CLEFT LIP AND PALATE

  • Eye Disease
  • Hospital
  • Surgery
  • Asia
  • Forecast
  • 4.3.6 Inotek Pharmaceuticals

pathologies associated with rapid loss of photoreceptors (Inotek, 2014b).

  • Eye Disease
  • Alcon, Inc.
  • Allergan plc
  • Pfizer Inc.
  • Santen Pharmaceutical Co., Ltd.

OPHTHALMIC SURGICAL PROCEDURES ##. ## Age-Related Macular Degeneration and Diabetic Retinopathy Ophthalmology involves the anatomy, function, pathology, and treatment of the eye.

  • Eye Disease
  • Healthcare
  • Hospital
  • Europe
  • Forecast
  • GLAUCOMA
  • GRAYBUG: IN THE NEWS

THESE POLYMERIC PARTICLES DEGRADE OVER TIME AND OFFER A SUSTAINED RELEASE OF THE DRUG DIRECTLY AT THE SITE OF PATHOLOGY INSIDE THE EYE.

  • Eye Disease
  • United States
  • Allergan plc
  • Neurotech Pharmaceuticals, Inc.
  • pSivida Corp.
  • inhibitors of ARF6 may have therapeutic value in melanoma.
  • Eye Disease
  • United States
  • World
  • Product Initiative
  • Navigen Pharmaceuticals, Inc.
  • Eye Disease
  • France
  • Company
  • Market Size
  • Ellex Medical Lasers Limited
  • QPI-1007 - DRUG PROFILE
  • QPI-1007 - DRUG PROFILE
  • Eye Disease
  • Neurology
  • United States
  • Product Initiative
  • Regeneron Pharmaceuticals, Inc.
  • BL-1230 - DRUG PROFILE
  • JUN 29, 2017: REDWOOD PHARMA SIGNS AGREEMENT REGARDING GMP PRODUCTION

SYL## is a compound based on RNAi being administered in the form of eye drops that block the synthesis of a receptor implicated in the pathology of dry eye syndrome.

  • Eye Disease
  • Ophthalmology
  • United States
  • World
  • Product Initiative

The ability to automatically create the montage is useful for imaging vasculature in potential pathologies that may extend into the periphery of the imaging plane.

  • CT Scan
  • Eye Disease
  • United States
  • Company Financials
  • GlobalData's company
  • May 30, 2017: Sylentis initiates a Phase III study for the treatment of dry eye syndrome
  • May 09, 2017: PharmaMar: Sylentis Announces New Preclinical and Clinical Data for its SYL1001 Molecule During ARVO 2017

Nicholas Johnson, Assistant Professor of Neurology, Pediatrics and Pathology at the University of Utah.

  • Eye Disease
  • Neurology
  • United States
  • Product Initiative
  • Flex Pharma, Inc.